Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

The new definition of pulmonary hypertension

M. M. Hoeper
European Respiratory Journal 2009 34: 790-791; DOI: 10.1183/09031936.00056809
M. M. Hoeper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Despite the progress that has been made in the field of pulmonary hypertension (PH) 1–3, there is no unifying and globally accepted definition of the condition. The first official haemodynamic definition of PH was proposed at the First World Symposium on Pulmonary Hypertension which took place 1973 in Geneva, Switzerland as a World Health Organization (WHO)-sponsored meeting 4. This conference was triggered by the previous epidemic of PH associated with the appetite suppressant aminorex 5. As such, the focus of that meeting was primary pulmonary hypertension (PPH), as compared to the other forms of PH. After a long and sometimes heated debate the consensus was to define PPH by a mean pulmonary artery pressure (P̄pa) >25 mmHg at rest or >30 mmHg during exercise in the presence of a pulmonary capillary wedge pressure (Ppcw) ≤15 mmHg.

This definition was later extended to other forms of pulmonary arterial hypertension (PAH) 6. It stood the test of time for >30 yrs, but was challenged during the Fourth World Symposium on Pulmonary Hypertension, which took place 2008 in Dana Point, CA, USA. There were several reasons for this: 1) the old definition did not take into account other forms of PH; 2) the threshold of P̄pa …

View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 34 Issue 4 Table of Contents
European Respiratory Journal: 34 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The new definition of pulmonary hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The new definition of pulmonary hypertension
M. M. Hoeper
European Respiratory Journal Oct 2009, 34 (4) 790-791; DOI: 10.1183/09031936.00056809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The new definition of pulmonary hypertension
M. M. Hoeper
European Respiratory Journal Oct 2009, 34 (4) 790-791; DOI: 10.1183/09031936.00056809
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Statement of interest
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Nintedanib in chILD: a small step
  • GM-CSF targeting in COVID-19
  • EBAP: reflections on 20 years of CME in respiratory medicine
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society